Item Type | Name |
Concept
|
Macrophage Activation
|
Concept
|
Macrophages
|
Concept
|
Macrophage Colony-Stimulating Factor
|
Concept
|
Granulocyte-Macrophage Colony-Stimulating Factor
|
Concept
|
Receptor, Macrophage Colony-Stimulating Factor
|
Concept
|
Macrophages, Alveolar
|
Concept
|
Macrophage Inflammatory Proteins
|
Academic Article
|
Targeted PPAR{gamma} deficiency in alveolar macrophages disrupts surfactant catabolism.
|
Academic Article
|
PPARgamma regulates the expression of cholesterol metabolism genes in alveolar macrophages.
|
Academic Article
|
Inhaled corticosteroids and beta-agonists inhibit oxidant production by bronchoalveolar lavage cells from normal volunteers in vivo.
|
Academic Article
|
Restoration of PPAR? reverses lipid accumulation in alveolar macrophages of GM-CSF knockout mice.
|
Academic Article
|
Novel murine model of chronic granulomatous lung inflammation elicited by carbon nanotubes.
|
Academic Article
|
Alveolar macrophage activation in obese patients with obstructive sleep apnea.
|
Academic Article
|
Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis.
|
Academic Article
|
Alveolar macrophage cathelicidin deficiency in severe sarcoidosis.
|
Academic Article
|
Our new understanding of pulmonary alveolar proteinosis: what an internist needs to know.
|
Academic Article
|
The prostacyclin analogue treprostinil blocks NFkappaB nuclear translocation in human alveolar macrophages.
|
Academic Article
|
Nitric oxide blocks inflammatory cytokine secretion triggered by CD23 in monocytes from allergic, asthmatic patients and healthy controls.
|
Academic Article
|
Circulating monocytes from patients with primary pulmonary hypertension are hyporesponsive.
|
Academic Article
|
Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.
|
Academic Article
|
Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis.
|
Academic Article
|
Plasmapheresis, GM-CSF, and alveolar proteinosis.
|
Academic Article
|
Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis.
|
Academic Article
|
PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor.
|
Academic Article
|
Surfactant blocks lipopolysaccharide signaling by inhibiting both mitogen-activated protein and IkappaB kinases in human alveolar macrophages.
|
Academic Article
|
Peroxisome proliferator-activated receptor gamma activity is deficient in alveolar macrophages in pulmonary sarcoidosis.
|
Academic Article
|
Elevated IL-10 inhibits GM-CSF synthesis in pulmonary alveolar proteinosis.
|
Academic Article
|
Pulmonary alveolar proteinosis. Clinical manifestations and optimal treatment strategies.
|
Academic Article
|
Serum cholestenoic acid as a potential marker of pulmonary cholesterol homeostasis: increased levels in patients with pulmonary alveolar proteinosis.
|
Academic Article
|
Elevated monocyte chemotactic proteins 1, 2, and 3 in pulmonary alveolar proteinosis are associated with chemokine receptor suppression.
|
Academic Article
|
Multiplexed particle-based anti-granulocyte macrophage colony stimulating factor assay used as pulmonary diagnostic test.
|
Academic Article
|
Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor.
|
Academic Article
|
An inverse relationship between peroxisome proliferator-activated receptor gamma and allergic airway inflammation in an allergen challenge model.
|
Academic Article
|
Suppression of activin A in autoimmune lung disease associated with anti-GM-CSF.
|
Academic Article
|
Human antibodies for immunotherapy development generated via a human B cell hybridoma technology.
|
Academic Article
|
An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis.
|
Academic Article
|
ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis.
|
Academic Article
|
Depressed peroxisome proliferator-activated receptor gamma (PPargamma) is indicative of severe pulmonary sarcoidosis: possible involvement of interferon gamma (IFN-gamma).
|
Academic Article
|
A novel 1,25-dihydroxyvitamin D-activin A pathway in human alveolar macrophages is dysfunctional in patients with pulmonary alveolar proteinosis (PAP).
|
Academic Article
|
Deletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response.
|
Academic Article
|
Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management.
|
Academic Article
|
Alveolar macrophages of GM-CSF knockout mice exhibit mixed M1 and M2 phenotypes.
|
Academic Article
|
Carbon nanotube-induced pulmonary granulomatous disease: twist1 and alveolar macrophage m1 activation.
|
Academic Article
|
A Pneumocyte-Macrophage Paracrine Lipid Axis Drives the Lung toward Fibrosis.
|